Schering-Plough
SGP
#508
Rank
A$67.02 B
Marketcap
N/A
Share price
0.00%
Change (1 day)
N/A
Change (1 year)
Schering-Plough was a major American pharmaceutical company that developed and marketed a range of prescription drugs. In 2009, Schering-Plough was acquired by Merck & Co. in a $41 billion USD deal.

Revenue for Schering-Plough (SGP)

Revenue in 2008: A$26.84 Billion

In 2008 the company made a revenue of A$26.84 Billion.The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Schering-Plough from 1996 to 2008

Annual revenue

Year Revenue Change
2008A$26.84 B
2006A$15.37 B11.42%
2005A$13.79 B14.94%
2004A$12.00 B-0.74%
2003A$12.09 B-18.13%
2002A$14.77 B3.86%
2001A$14.22 B-0.13%
2000A$14.24 B6.96%
1999A$13.31 B13.61%
1998A$11.72 B19.16%
1997A$9.83 B19.84%
1996A$8.20 B